Literature DB >> 24202176

Cell type-specific signaling function of RhoA GTPase: lessons from mouse gene targeting.

Xuan Zhou1, Yi Zheng.   

Abstract

RhoA GTPase is a key intracellular regulator of actomyosin dynamics and other cell functions, including adhesion, proliferation, survival, and gene expression. Most of our knowledge of RhoA signaling function is from studies in immortalized cell lines utilizing inhibitors or dominant mutant overexpression, both of which are limited in terms of specificity, dosage, and clonal variation. Recent mouse gene targeting studies of rhoA and its regulators/effectors have revealed cell type-specific signaling mechanisms in the context of mammalian physiology. The new knowledge may present therapeutic opportunities for the rational targeting of RhoA signaling-mediated pathophysiologies.

Entities:  

Keywords:  Cellular Regulation; Gene Knock-out; Mouse Genetics; Rho GTPases; Signaling

Mesh:

Substances:

Year:  2013        PMID: 24202176      PMCID: PMC3868732          DOI: 10.1074/jbc.R113.515486

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  93 in total

1.  Inhibition of RhoA GTPase activity enhances hematopoietic stem and progenitor cell proliferation and engraftment.

Authors:  Gabriel Ghiaur; Andrew Lee; Jeff Bailey; Jose A Cancelas; Yi Zheng; David A Williams
Journal:  Blood       Date:  2006-05-18       Impact factor: 22.113

Review 2.  Rho and Ras GTPases in axon growth, guidance, and branching.

Authors:  Alan Hall; Giovanna Lalli
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

3.  B lymphocyte-specific, Cre-mediated mutagenesis in mice.

Authors:  R C Rickert; J Roes; K Rajewsky
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

4.  RhoA protects the mouse heart against ischemia/reperfusion injury.

Authors:  Sunny Yang Xiang; Davy Vanhoutte; Dominic P Del Re; Nicole H Purcell; Haiyun Ling; Indroneal Banerjee; Julie Bossuyt; Richard A Lang; Yi Zheng; Scot J Matkovich; Shigeki Miyamoto; Jeffery D Molkentin; Gerald W Dorn; Joan Heller Brown
Journal:  J Clin Invest       Date:  2011-07-11       Impact factor: 14.808

Review 5.  Signaling role of Cdc42 in regulating mammalian physiology.

Authors:  Jaime Melendez; Matthew Grogg; Yi Zheng
Journal:  J Biol Chem       Date:  2010-11-29       Impact factor: 5.157

6.  Rho GTPases are over-expressed in human tumors.

Authors:  G Fritz; I Just; B Kaina
Journal:  Int J Cancer       Date:  1999-05-31       Impact factor: 7.396

7.  RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis.

Authors:  Anne Hakem; Otto Sanchez-Sweatman; Annick You-Ten; Gordon Duncan; Andrew Wakeham; Rama Khokha; Tak W Mak
Journal:  Genes Dev       Date:  2005-08-17       Impact factor: 11.361

8.  Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells.

Authors:  N W Gale; P Baluk; L Pan; M Kwan; J Holash; T M DeChiara; D M McDonald; G D Yancopoulos
Journal:  Dev Biol       Date:  2001-02-15       Impact factor: 3.582

9.  G13 is an essential mediator of platelet activation in hemostasis and thrombosis.

Authors:  Alexandra Moers; Bernhard Nieswandt; Steffen Massberg; Nina Wettschureck; Sabine Grüner; Ildiko Konrad; Valerie Schulte; Barsom Aktas; Marie-Pierre Gratacap; Melvin I Simon; Meinrad Gawaz; Stefan Offermanns
Journal:  Nat Med       Date:  2003-10-05       Impact factor: 53.440

10.  Rho1 interacts with p120ctn and alpha-catenin, and regulates cadherin-based adherens junction components in Drosophila.

Authors:  Craig R Magie; Delia Pinto-Santini; Susan M Parkhurst
Journal:  Development       Date:  2002-08       Impact factor: 6.868

View more
  25 in total

Review 1.  RhoA/ROCK pathway: implication in osteoarthritis and therapeutic targets.

Authors:  Zhenhan Deng; Yiming Jia; Haifeng Liu; Miao He; Yuntao Yang; Wenfeng Xiao; Yusheng Li
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

Review 2.  G17V RHOA: Genetic evidence of GTP-unbound RHOA playing a role in tumorigenesis in T cells.

Authors:  Shigeru Chiba; Terukazu Enami; Seishi Ogawa; Mamiko Sakata-Yanagimoto
Journal:  Small GTPases       Date:  2015-06-23

3.  Recombinant anthrax lethal toxin inhibits cell motility and invasion in breast cancer cells through the dysregulation of Rho GTPases.

Authors:  Dana El-Chami; Maria Al Haddad; Ralph Abi-Habib; Mirvat El-Sibai
Journal:  Oncol Lett       Date:  2020-12-31       Impact factor: 2.967

Review 4.  Approaches of targeting Rho GTPases in cancer drug discovery.

Authors:  Yuan Lin; Yi Zheng
Journal:  Expert Opin Drug Discov       Date:  2015-06-18       Impact factor: 6.098

5.  RhoA signaling increases mitophagy and protects cardiomyocytes against ischemia by stabilizing PINK1 protein and recruiting Parkin to mitochondria.

Authors:  Michelle Tu; Valerie P Tan; Justin D Yu; Raghav Tripathi; Zahna Bigham; Melissa Barlow; Jeffrey M Smith; Joan Heller Brown; Shigeki Miyamoto
Journal:  Cell Death Differ       Date:  2022-06-27       Impact factor: 15.828

6.  ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma.

Authors:  Yanyan Wang; Yue Zhang; Jiaqi Mi; Chenchen Jiang; Qiang Wang; Xinwei Li; Menglin Zhao; Zhijun Geng; Xue Song; Jing Li; Lugen Zuo; Sitang Ge; Zining Zhang; Hexin Wen; Zishu Wang; Fang Su
Journal:  Oncogene       Date:  2022-06-21       Impact factor: 8.756

7.  Cytokinesis failure in RhoA-deficient mouse erythroblasts involves actomyosin and midbody dysregulation and triggers p53 activation.

Authors:  Diamantis G Konstantinidis; Katie M Giger; Mary Risinger; Suvarnamala Pushkaran; Ping Zhou; Phillip Dexheimer; Satwica Yerneni; Paul Andreassen; Ursula Klingmüller; James Palis; Yi Zheng; Theodosia A Kalfa
Journal:  Blood       Date:  2015-07-30       Impact factor: 22.113

8.  Thiopurines correct the effects of autophagy impairment on intestinal healing - a potential role for ARHGAP18/RhoA.

Authors:  Marileen M C Prins; Francesca P Giugliano; Manon van Roest; Stan F J van de Graaf; Pim J Koelink; Manon E Wildenberg
Journal:  Dis Model Mech       Date:  2021-04-23       Impact factor: 5.758

9.  Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cells.

Authors:  J Joseph Melenhorst; Rong Fan; Zhiliang Bai; Stefan Lundh; Dongjoo Kim; Steven Woodhouse; David M Barrett; Regina M Myers; Stephan A Grupp; Marcela V Maus; Carl H June; Pablo G Camara
Journal:  J Immunother Cancer       Date:  2021-05       Impact factor: 13.751

10.  Obesity alters the ovarian proteomic response to zearalenone exposure†.

Authors:  M Estefanía González-Alvarez; Bailey C McGuire; Aileen F Keating
Journal:  Biol Reprod       Date:  2021-07-02       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.